Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11753398 Therapeutic compounds

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
August 27, 2021
Date of Patent
September 12, 2023
Patent Application Number
17459598
Patent Citations
‌
US Patent 7501538 Aryl and heteroaryl compounds, compositions and methods of use
‌
US Patent 7544699 Aryl and heteroaryl compounds, compositions, and methods of use
‌
US Patent 7872133 Tricyclic heterocycle compound
‌
US Patent 8039674 Compound having S1P receptor binding potency and use thereof
‌
US Patent 8653305 Compound having S1P receptor binding potency and use thereof
‌
US Patent 8987271 2,2′-biphenazine compounds and methods useful for treating disease
‌
US Patent 10011595 Ethyldiamine orexin receptor antagonists
‌
US Patent 10696654 Therapeutic compounds
‌
US Patent 10611760 Therapeutic compounds as inhibitors of the orexin-1 receptor
‌
US Patent 11130746 Therapeutic compounds
•••
Patent Citations Received
‌
US Patent 12024509 Therapeutic compounds as inhibitors of the orexin-1 receptor
0
Patent Inventor Names
Barrie P. Martin
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11753398
Patent Primary Examiner
‌
Erich A Leeser
CPC Code
‌
C07D 401/14

Find more entities like US Patent 11753398 Therapeutic compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.